JP Morgan Chase
CERO

JP Morgan Chase’s CERo Therapeutics CERO Stock Holding History

JP Morgan Chase’s Portfolio CERO Stock Details CERO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– -$1 – 7734
2025
Q1 		– Hold
0
– – – 7272
2024
Q4 		– Hold
0
– – – 7323
2024
Q3 		– Hold
0
– – – 7726
2024
Q2 		– Hold
0
– – – 7300
2024
Q1 		– Hold
0
– – – 7271
2022
Q4 		– Sell
-50
Closed -$1.01M – 7067
2022
Q3 		$1.01M Buy
+50
New +$1.01M ﹤0.01% 3984

Other funds holding CERO

PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase's CERO Position: Q2 2025 in Review

JP Morgan Chase held its CERo Therapeutics (CERO) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7734.

JP Morgan Chase first reported a position in CERO in Q3 2022 and has held it in 1 quarter since. The position peaked at $1.01M in Q3 2022. 8 funds tracked by Wall St. Rank hold CERO as of Q2 2025.

  • JP Morgan Chase held 0 shares of CERo Therapeutics worth $0 as of Q2 2025.
  • JP Morgan Chase left its CERo Therapeutics share count unchanged in Q2 2025.
  • CERo Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2025, its #7734 holding.
  • JP Morgan Chase first reported a position in CERo Therapeutics in Q3 2022 and has held it in 1 quarter since.
  • JP Morgan Chase's CERo Therapeutics position peaked at $1.01M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held CERo Therapeutics as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.